ZOSTAVAX reducerede signifikant forekomsten af zostertilfælde sammenlignet med placebobehandlingen (hhv.
ZOSTAVAX significantly decreased the incidence of zoster compared with placebo (315 [5.4/ 1000 person-years] vs.